← Back to Search
Age, Gene/Environment Susceptibility-Reykjavik Study: Multidisciplinary Applied Phenomics.
T. Harris, L. Launer, G. Eiriksdottir, O. Kjartansson, P. Jonsson, G. Sigurdsson, G. Thorgeirsson, T. Aspelund, M. García, M. Cotch, H. Hoffman, V. Gudnason
Published 2007 · Medicine
Referenced 1 time by Citationsy Users
Download PDFAnalyze on Scholarcy
In anticipation of the sequencing of the human genome and description of the human proteome, the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik) was initiated in 2002. AGES-Reykjavik was designed to examine risk factors, including genetic susceptibility and gene/environment interaction, in relation to disease and disability in old age. The study is multidisciplinary, providing detailed phenotypes related to the cardiovascular, neurocognitive (including sensory), and musculoskeletal systems, and to body composition and metabolic regulation. Relevant quantitative traits, subclinical indicators of disease, and medical diagnoses are identified by using biomarkers, imaging, and other physiologic indicators. The AGES-Reykjavik sample is drawn from an established population-based cohort, the Reykjavik Study. This cohort of men and women born between 1907 and 1935 has been followed in Iceland since 1967 by the Icelandic Heart Association. The AGES-Reykjavik cohort, with cardiovascular risk factor assessments earlier in life and detailed late-life phenotypes of quantitative traits, will create a comprehensive study of aging nested in a relatively genetically homogeneous older population. This approach should facilitate identification of genetic factors that contribute to healthy aging as well as the chronic conditions common in old age.
This paper references
Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967–1991— the Reykjavik Study
S. Vilbergsson (1997)
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
M. Folstein (1975)
Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.
L. Kuller (1998)
The mini international neuropsychiatric interview
Y. Lecrubier (1998)
Comprehensive Clinical Assessment in Community Setting: Applicability of the MDS‐HC
J. Morris (1997)
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study.
B. Goodpaster (2001)
Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk
S. Saevarsdottir (2005)
The Human Phenome Project
N. Freimer (2003)
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
D. Black (2003)
Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study.
M. Andrésdóttir (2003)
Adipose tissue: a regulator of inflammation.
C. Juge-Aubry (2005)
Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders.
H. Tulinius (1997)
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
A. Festa (2002)
1 User’s guide
D. Gibbon (1998)
Endophenotypes Successfully Lead to Gene Identification: Results from the Collaborative Study on the Genetics of Alcoholism
D. Dick (2006)
Increasing sex difference in bone strength in old age: The Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK).
G. Sigurdsson (2006)
Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.
W. Ershler (2000)
Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study.
M. Budoff (1996)
A Reassessment of Genetic Diversity in Icelanders: Strong Evidence from Multiple Loci for Relative Homogeneity Caused by Genetic Drift
A. Helgason (2003)
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D. Sheehan (1998)
Multi-Ethnic Study of Atherosclerosis: objectives and design.
D. Bild (2002)
Familial risk of lung carcinoma in the Icelandic population.
S. Jónsson (2004)
Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli
Ethan Gahtan (1999)
The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study.
L. Launer (1995)
Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study.
M. Andrésdóttir (2002)
Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology
M. Nanes (2003)
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
J. Hogg (2004)
Designing the national resident assessment instrument for nursing homes.
J. Morris (1990)
Cerebral white matter lesions and cognitive function: The Rotterdam scan study
Jan Cees De Groot (2000)
Atherosclerosis is an inflammatory disease.
R. Ross (1999)
Defining the Phenotype in Human Genetic Studies: Forward Genetics and Reverse Phenotyping
T. Schulze (2004)
Overweight, weight loss, and risk of coronary heart disease in older women. The NHANES I Epidemiologic Follow-up Study.
T. Harris (1993)
Race-Specific Relationships Between Coronary and Carotid Artery Calcification and Carotid Intimal Medial Thickness
L. Wagenknecht (2004)
Size at birth and coronary artery disease in a population with high birth weight.
I. Gunnarsdottir (2002)
A community-based study of dementia: the Rotterdam Elderly Study.
M. M. Breteler (1992)
Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study
E. Sigurdsson (1995)
Complement Factor H Polymorphism in Age-Related Macular Degeneration
Robert J. Klein (2005)
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
J. Danesh (2004)
This paper is referenced by
Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study
E. Olafsdottir (2011)
Rye bread consumption in early life and reduced risk of advanced prostate cancer
Johanna E. TorfadottirUnnur (2012)
The effects of known type 2 diabetes susceptibility loci on complications of the disease
Valborg Guðmundsdóttir (2012)
Norms for the Icelandic version of the ACE-III : effects of age and education
Una Sólveig Jóakimsdóttir (2016)
FNIH-defined Sarcopenia Predicts Adverse Outcomes Among Community-dwelling Older People in Taiwan : Results from the ILan Longitudinal Aging Study Running title : FNIH-defined sarcopenia and adverse outcomes
Ting-Ching Tang (2017)
Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study.
F. Jónasson (2011)
Glycemic Status and Brain Injury in Older Individuals
J. Saczynski (2009)
Personalized Epigenomic Signatures That Are Stable Over Time and Covary with Body Mass Index
A. Feinberg (2010)
Coronary artery calcium distributions in older persons in the AGES-Reykjavik study
E. Gudmundsson (2012)
Fat Distribution and Mortality: The AGES-Reykjavik Study
A. Koster (2015)
Bone Marrow Fat Changes After Gastric Bypass Surgery Are Associated With Loss of Bone Mass
Tiffany Kim (2017)
Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults
S. Shanbhag (2019)
ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals
N. A. Bihlmeyer (2018)
An Evidence-Based Comparison of Operational Criteria for the Presence of Sarcopenia
T. Dam (2014)
283 THE PRESENCE OF TOTAL KNEE OR HIP REPLACEMENTS DUE TO OA STRENGTHENS THE POSITIVE ASSOCIATION BETWEEN HAND OA AND ATHEROSCLEROSIS IN FEMALES: THE AGES-REYKJAVIK STUDY
H. Jonsson (2010)
GENETIC PREDICTORS OF METABOLIC SIDE EFFECTS OF DIURETIC THERAPY
D. Águila (2014)
An Overview of the Design, Implementation, and Analyses of Longitudinal Studies on Aging
A. Newman (2010)
Intra-individual change over time in DNA methylation with familial clustering.
H. Bjornsson (2008)
Bioinformatic and biological analysis of DNA methylation in the human genome
Martin Ingi Sigurðsson (2011)
Muscle Quality and Myosteatosis: Novel Associations With Mortality Risk: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study.
I. Reinders (2016)
Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality.
T. Hida (2020)
Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque
J. Bis (2011)
Grip Strength Cutpoints for the Identification of Clinically Relevant Weakness
D. Alley (2014)
Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms
Yen-Feng Lin (2019)
Occupational health epidemiology in the Nordic countries – status and trends
M. Albin (2009)
Sex differences in the association between body mass index and total hip or knee joint replacement resulting from osteoarthritis
J. Franklin (2009)
Cardiac Function and Features of Brain Aging
Pulse Pressure Relation to Aortic and Left Ventricular Structure in the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study
Alyssa A. Torjesen (2014)
Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: a cross-sectional study.
M. Leosdottir (2010)
Genome-Wide Joint Meta-Analysis of SNP and SNP-by-Smoking Interaction Identifies Novel Loci for Pulmonary Function
D. Hancock (2012)
A novel, multiplexed targeted mass spectrometry assay for quantification of complement factor H (CFH) variants and CFH‐related proteins 1–5 in human plasma
P. Zhang (2017)
Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans
D. V. Keulen (2019)See more